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Mannose-binding lectin (MBL), a pattern-recognition molecule in serum, recognizes speciﬁc hexose
sugars rich in mannose and N-acetylglucosamine on bacterium, yeasts, viruses as well as apoptotic cells.
It has been well-identiﬁed that MBL has antiviral effects via binding to seasonal inﬂuenza H1 and H3
subtype viruses. Inﬂuenza A (H7N9) virus, a novel reassortant virus to human population, possesses the
surface hemagglutinin (HA) and neuraminidase (NA) genes from duck and wild-bird inﬂuenza viruses
and internal genes from poultry H9N2 viruses. As of Dec 7th, 2014, a total of 467 human infections and
183 fatal cases have been identiﬁed. Here, recombinant human (rh) MBL was tested for its binding and
effects on hemagglutination inhibition (HI) and NA activity inhibition (NAI) of avian H7N9, H9N2 and
human H3N2 viruses. We discovered that rhMBL exhibited a strong binding to H7N9 virus as human
H3N2 did at high virus titers. However, it performed a signiﬁcantly weaker HI activity effect on H7N9
comparing to those of H3N2 and H9N2, even at a much higher concentration (3.67 ± 0.33 vs.
0.026 ± 0.001 and 0.083 ± 0.02 mg/mL, respectively). Similarly, minor NAI effect of rhMBL, even at up to
10 mg/mL, was found on H7N9 virus while it displayed signiﬁcant effects on both H3N2 and H9N2 at a
lowest concentration of 0.0807 ± 0.009 and 0.0625 mg/mL, respectively. The HI and NAI effects of rhMBL
were calcium-dependent and mediated by lectin domain. Our ﬁndings suggest that MBL, the host innate
molecule, has differential interference effects with human and avian inﬂuenza virus and limited antiviral
effect against H7N9 virus.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Host innate immunity plays a critical role in the early phase of
infection. This ﬁrst-line defense against pathogens is mediated by a
variety of pattern-recognition molecules including collectins, toll-
like receptors and ﬁcolins as well as inﬂammatory cytokines and
type I interferon or macrophages and natural killer cells. Mannose-
binding lectin (MBL) is one of collectins circulating in the serum
and synthesized by liver. It consists of collagenous domains andDisease Control and Preven-
n, Key Laboratory for Medical
mission, 155 Changbai Road,
Inc. This is an open access article ucarbohydrate recognition domains (CRD). The CRDs recognize
sugars including D-mannose, N-acetylmannosamine, N-acetylglu-
cosamine and L-fucose on the surface of many pathogens in a
calcium-dependent manner [1]. Previous studies showed that MBL
can bind to a range of clinically relevant microorganisms such as
Staphylococcus aureus, Candida Albicans [2], HIV, SARS-CoV, Ebola
virus, HSV, inﬂuenza virus [3e6]. The binding of MBL to microor-
ganisms is presumed to induce MBL conformational changes that
allow the molecule to initiate viral neutralization or kill virus via
opsonization or complement activation [7].
Inﬂuenza A virus, a segmented single-stranded negative-sense
RNA virus, belongs to orthomyxoviridae and is subtyped according
to the antigenic properties of their envelope glycoproteins, HA and
NA. Currently, 16 HA subtypes and 9 NA subtypes circulate in birds.
Among them, only seasonal H1N1 and H3N2 viruses circulate in
human population [8]. Occasionally, some subtypes of aviannder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Distances from the potential N-linked glycosylation sites (NGS) to receptor binding
domain or NA activity region (Å).
NGS Protein Distances from the NGS to functional region (Å)
H3N2WT H9N2RG H7N9Vac
63 HA 27.3 e e
95 HA e 23.2 e
122 HA 26.9 e e
128 HA e 17.6 e
126 HA 24.3 e e
133 HA 16 e e
144 HA 18.9 e e
165 HA 24.1 e e
198 HA e 16.2 e
240 HA e e 37.3
246 HA 22.2 e e
86 NA 29.4 29.4 30
146 NA 20.8 21.2 28.9
200 NA 18.1 18.4 18.4
234 NA 29.4 29.5 e
329 NA 26.5 e e
402 NA 22.4 22.7 e
e: Denotes the absence of NGS in the corresponding virus.
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range of clinical symptoms and outcomes, such as conjunctivitis,
mild upper respiratory tract disease, as well as severe pneumonia
and death [9e12]. Viral HA and NA assist virus binding, entry and
releasing during infection cycle. Their potential N-linked glycosyl-
ation sites (NGS) can be glycosylated, which might allow their
binding to host MBL. It has been found that the glycan at residue
165 in H3N2 HA was of high-mannose and MBL neutralized viral
infectivity via it. Many lines of evidences have shown that the MBL
plays an important role in ﬁghting against seasonal ﬂu [13e15].
However, little is known about the interactions between avian
inﬂuenza virus and the innate molecules. Avian inﬂuenza H7N9
virus is novel to human population [16,17], which contains the
surface HA and NA genes from duck andwild-bird inﬂuenza viruses
and internal genes from poultry H9N2 viruses. Unlike other H7
viruses that generally cause mild symptoms such as conjunctivitis
or inﬂuenza-like illness (except one fatal case infected with H7N7
in Netherlands in 2003), H7N9 virus usually results in severe
pneumonia or respiratory failure in human. Here, we examined the
interactions of MBL with avian inﬂuenza virus H7N9, H9N2 and
human virus H3N2. Furthermore, we studied the molecule mech-
anisms for them by structure modeling.
2. Materials and methods
2.1. Virus
The vaccine strain A/Anhui/1/2013(H7N9) (NIBRG-268) was ob-
tained from National Institute for Biological Standards and Control
(UK), namely H7N9Vac. The virus bears the HA and NA of A/Anhui/1/
2013(H7N9) and internal genes ofA/PuertoRico/8/1934 (PR8,H1N1);
A/Brisbane/10/2007(H3N2) was named as H3N2WT in the study;
H9N2 virus, a reassortant bearing the HA, NA from A/Hongkong/
33982/2009(H9N2) and internal genes of PR8, was named as
H9N2RG. The reassortant H7N1AH1 HAþPR8 NA was with HA of A/
Anhui/1/2013 and seven genes of PR8,which is rescued as previously
reported [18]. H7N9Vac, H3N2WT and H7N1AH1 HAþPR8 NA were
propagated in 9e11-day-old embryonated chicken eggs, H9N2RG
was grown in Madin-Darby canine kidney (MDCK) cells (ATCC, USA)
with Modiﬁed Eagle's Medium (invitrogen, USA)containing 2 mg/mL
N-tosyl-L-phenylalanine chloromethyl ketone (TPCK)etreated
trypsin (Sigma, USA). Virus stockswere puriﬁed by adsorption to and
elution from turkey red blood cells (TRBCs) and stored at80Cuntil
use [19]. Virus titer was determined by titration in MDCK cells and
the tissue culture infectious dose affecting 50% of the cultures
(TCID50) is calculated by the ReedeMuench formula [20].
2.2. Detection of MBL binding to inﬂuenza virus
Recombinant human MBL (rhMBL) was purchased from Sino
Biological Inc (Beijing, China). Ninety-six-well plates were coated
with 2  105 TCID50 inﬂuenza virus at a volume of 100 ml/well for
overnight at 4 C, then were blocked for 1 h with 1% Bovine Serum
Albumin (BSA, Roche, Switzerland) at 37 C. Different concentra-
tions of rhMBL (0, 1, 3, 5, 7 mg/mL) were added and incubated for
1 h at 37 C. The virus-dose dependent binding assay was con-
ducted as that wells were precoated with 2  102, 2  103, 2  104
and 2 105 TCID50 inﬂuenza viruses per well. Then 3 mg/mL rhMBL
was added and incubated for 1 h at 37 C. The binding was
detected by the biotinylated human MBL pAb (0.2 mg/mL) (R&D,
USA), followed by streptavidin-horseradish peroxidase (HRP)
(1:200) (R&D, USA) and tetramethylbenzidine substrate solution
(BD, USA), the reaction was stopped by 2 M H2SO4 and the Optical
Density (OD) at 450 nm was measured by ELISA reader (Perkin-
Elmer, USA). The wells coated with 10 mg/mL mannan fromSaccharomyces cerevisiae (Sigma, USA) or coating buffer (Kirke-
gaard& Perry Laboratories, USA) were used as positive control and
negative control respectively. The test was performed in duplicates
and in three independent experiments, absorbance from negative
control was subtracted and results were normalized to positive
control, data was expressed as a relative absorbance value using
mean ± SEM (%).2.3. Hemagglutination inhibition (HI) assays
HI assay was performed in V-bottom 96-well plates as previ-
ously described [20]. Brieﬂy, 25 mL inﬂuenza virus (4HAU) was
mixed with 25 mL rhMBL of different concentrations diluted in
Hank's Balanced Salt Solution (HBSS) containing 1.26 mM Ca2þ for
1 h at 37 C, then 50 mL 1% TRBC was added to the mixture and
incubate at room temperature for 30 min. For HI reverse assay:
rhMBL was diluted in HBSS containing 10 mM EDTA or 10 mg/mL
mannan, then incubated with 4 HAU of inﬂuenza virus. The results
were expressed as the minimum inhibitory concentration (MIC) of
rhMBL that exhibited HI effect.2.4. Neuraminidase activity inhibition (NAI) assays
Inﬂuenza virus NA activity was measured by ELISA in which
peanut agglutinin conjugated with HRP was used to detect b-D-
galactose-N-acetylglucosamine exposed after removal of sialic acid
from fetuin [21]. Appropriate amounts of virus in Dulbecco's 1X PBS
with CaCl2 and MgCl2 (Life Technologies, USA) were used to
perform the NAI assays. Different concentrations of rhMBL were
diluted in HBSS containing Ca2þ andmixed with inﬂuenza virus in a
total volume of 100 mL and preincubated at 37 C for 1 h, and then
transferred to wells precoated with fetuin (Sigma, USA) and incu-
bated at 37 C for 4 h, After washing, 100 mL of HRP-labeled peanut
lectin (3 mg/mL) was added and after 1 h at room temperature, the
wells were washed and o-phenylenediamine dihydrochloride in
citrate buffer was added, reaction was stopped by 2 M H2SO4, and
the OD at 492 nm was measured. The wells only with virus were
used as the positive control, the OD of wells with HBSS used as a
negative control was subtracted. Results were expressed as relative
NA activity (%) calculated as the OD of the tested wells with virus
and rhMBL divided by the OD of the wells with only virus.
Table 2
HI titer of rhMBL against inﬂuenza A viruses.
Concentrations inhibiting hemagglutination of IAV by rhMBL (mg/mL)
H3N2WT H9N2RG H7N9Vac H7N1AH1 HAþPR8 NA
MBL 0.026 ± 0.005 0.083 ± 0.02 1.42 ± 0.239 3.67 ± 0.33
þEDTAa >0.5 ND ND ND
þmannanb >0.5 ND ND ND
Results are expressed as mean ± SEM of three independent experiments. ND: not determined.
H3N2WT: A/Brisbane/10/2007(H3N2) wild-type; H9N2RG: virus with the HA, NA from A/Hongkong/33982/2009(H9N2)and internal genes from A/Puerto Rico/8/1934(H1N1);
H7N9Vac: virus with the HA, NA from A/Anhui/1/2013(H7N9) and internal genes from A/Puerto Rico/8/1934(H1N1); H7N1AH1 HAþPR8 NA: virus with HA from A/Anhui/1/
2013(H7N9) and other seven genes from A/Puerto Rico/8/1934(H1N1).
a The HI test was performed in the presence of 5 mM EDTA and rhMBL of different concentrations. The maxim concentration of MBL for testing is 0.5 mg/mL.
b The HI test was performed in the presence of 5 mg/mL mannan and rhMBL of different concentrations. The maxim concentration of MBL for testing is 0.5 mg/mL.
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The HA and NA 3D structures were predicted by using the ho-
mology modeling method of SWISS-MODEL [22]. The modeling
structures, corresponding templates and identities are shown in
Supplementary Table S1. Potential NGS were identiﬁed with the
NetNGlyc 1.0 server (http://www.cbs.dtu.dk/services/NetNGlyc/)
using artiﬁcial neural networks that examine the context of Asn-Xaa-
Ser/Thr sequences. The predicted NGS include 86, 146, 200, 234, 329
and 402 of NA, 79,105,138,141,142,149,160,181, 206, 249 and 262 of
HA (H3N2 numbering) (Table 1). The NGS at themodeling structures
werehighlighted in Fig. S1withPymol (DeLano Scientiﬁc). The trimer
structure of MBL was assembled using MBL crystal structure (PDB
code: 1HUP) with PISA [23] which generate the oligomeric forms of
protein according to the symmetry information. To quantify the
distance between RBD/NA activity region and each NGS, we
employed the averageEuclideandistanceof the center (Calphaatom)
of every RBD/NA activity region and the center (C alpha atom) ofNGS.
2.6. Statistical analysis
Differences between groups were tested using non-parametric
KruskaleWallis analysis of variance (ANOVA) for multiple com-
parisons using IBM SPSS Statistics 20.0 (IBM, USA) and p < 0.05 was
considered statistically signiﬁcant.
3. Results
3.1. Binding of rhMBL with seasonal and avian inﬂuenza viruses
The ELISA results showed that rhMBL bound both seasonal and
avian inﬂuenza viruses in vitro. Incubation with increasingFig. 1. Binding of rhMBL to puriﬁed inﬂuenza A virus. A. The dose-dependent binding of rhMB
(C), H9N2RG (-), H3N2WT (:), 1% BSA (;). B. The bindings of rhMBL to inﬂuenza virus
TCID50 inﬂuenza viruses H7N9Vac (C), H9N2RG (-) and H3N2WT (:), 3 mg/mL rhMBL was
detected by ELISA, as described in Materials and methods. The absorbance from negative co
Data are expressed as mean ± SEM (%) from three independent experiments.concentrations of rhMBL resulted in elevated levels of MBL bound
to immobilized inﬂuenza virus, reaching a plateau at 3 mg/mL
(Fig. 1A). Then, 3 mg/mL rhMBL was used to determine the afﬁnity
to increasing amounts of virus, revealing the virus-dose depen-
dent binding feature (Fig. 1B). High binding of rhMBL to the hu-
man H3N2 virus might be due to a relatively more NGS in its HA
and NA (Table S2), in addition to the glycans attached at the site of
165 as previously reported [14]. Beyond our expectation, H7N9
virus exhibited stronger binding than H9N2 virus, reaching a
comparable level as human H3N2 at higher titers of 2  104 and
2  105, although fewer NGS was observed in avian H7N9 than
avian H9N2 (Table S2). The differential binding of rhMBL to avian
virus might result from the types of oligosaccharide attached and
further investigations are needed. The ﬁnding demonstrated here
implied a possible antiviral effect initiated by rhMBL at early stage
of novel avian virus infection since naïve host lacked the pre-
existed cross-reactive or speciﬁc anti-HA or anti-NA antibodies.3.2. Weak HI interference with H7N9 virus by rhMBL
Initially, we discovered that the lowest concentration for rhMBL
(mg/mL, mean ± SEM) to abolish virus-mediated TRBC agglutination
was 1.42 ± 0.239, 0.083 ± 0.02, 0.026 ± 0.005 for H7N9vac, H9N2RG
and H3N2WT (Table 2), respectively. The HI effect could be reversed
in the presence of 5mM EDTA or 5mg/mLmannan, which indicates
that HI was calcium-dependent and mannan-inhibitable. We then
used a H7N1 reassortant obtained HA from H7N9 and other seven
segments from PR8 to exclude a possible hemadsorption by N9
reported elsewhere [24]. The MIC against the H7N1 was
3.67 ± 0.33 mg/mL (Table 2), which was remarkably higher than
those against H3N2 or H9N2 virus, indicating a weaker HI effect of
rhMBL on H7.L to inﬂuenza virus. Wells were precoated with 2  105TCID50 inﬂuenza virus H7N9Vac
increase with viral titer. Wells were precoated with 2  102, 2  103, 2  104, 2  105
used to detect the binding. Levels of rhMBL bound to immobilized inﬂuenza virus were
ntrol was subtracted and the results were normalized to positive control, the mannan.
Fig. 2. Inhibition of inﬂuenza virus Neuraminidase activity by rhMBL. A. Inhibition of H3N2 NA activity by rhMBL. Virus was incubated with increasing concentrations of rhMBL
(:), or with EDTA at ﬁnal concentration of 5 mM (◊), mannan at ﬁnal concentration of 5 mg/mL (B). B. Inhibition of H7N9, H9N2 NA activity by rhMBL. H7N9Vac (C) and H9N2RG
(-) were incubated with increasing concentrations of rhMBL. NA activity was measured by ELISA, as described in Materials and methods. C. The effects of 10 mg/mL rhMBL and
25 mM oseltamivir on NA activity of H7N9Vac. Results were expressed as relative NA activity (%) calculated as the OD of the tested wells with virus and rhMBL divided by the OD of
the wells only with virus. The dashed line represents 50% of the original NA activity. Data are expressed as mean ± SEM of three independent experiments. *p < 0.05.
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As shown in Fig. 2A, NA activity of H3N2was inhibited by rhMBL
in a dose-dependent manner, and the IC50 was 0.0807 ± 0.009 mg/
mL. Similarly, the rhMBL, at a concentration of 0.0625 mg/mL, could
inhibit the NA activity of H9N2 (Fig. 2B). Nevertheless, the relative
NA activity of H7N9 remained above 50% in the presence of
increasing concentration of rhMBL even at up to 10 mg/mL. By
contrast, the positive control, oseltamivir (Roche, Switzerland) at
the concentration of 25 mM (equivalent to 7.109 mg/mL), could
signiﬁcantly inhibit the NA activity of H7N9 (Fig. 2C). Furthermore,
the inhibition of H3N2NA activity by rhMBL could also be abolished
in the presence of 5 mM EDTA or 5 mg/mLmannan, suggesting that
the NAI was calcium-dependent and mediated by lectin domain.
3.4. Steric interference between MBL and NGS in HA and NA head
RBD in HA, including the motifs of 190-helix, 130- and 220-loop,
is one of important functional domains [25]. NA activity region is
composed of 8 functional residues (R118, D151, R152, R224, E276,
R292, R371 and Y406) and 11 framework residues (E119, R156,
W178, S179, D198, I222, E227, H274, E277, N294 and E425) [18]. To
elucidate a possible interference between MBL and the NGS around
the functional motifs: RBD in HA or the NA activity domain, we
compared NGS distribution in them by structure modeling (Fig. S1).
We also obtained the trimer form of MBL using the crystal structure
(PDB code: 1HUP) and measured the radius of MBL CRD which is at
least 30 Å. Although there are indications that trimers of MBL are
not biologically active and at least a tetramer form is needed for
activation of complement [26], 30 Å can be regard as the minimum
value. We subsequently calculated the average distances between
the NGS located around RBD or NA activity region (Table 1) and
speculated that their distance within the size of human MBL CRD,
30 Å, might affect the functions of HA or NA. As listed in Table S2
and Fig. S1, only one conserved NGS on HA head was detected at
position 240 in the avian H7N9while different patternwas found in
H3 and H9 (63, 122, 126, 133, 144, 165, 246 for H3; 95,128,198 for
H9). The distances of NGS located in H3 and H9 from its individual
RBD all are within 30 Å while it is of 37.3 Å at 240NGS in H7N9.
Furthermore, the NGS at residue 165, 246 [14,27] were indeed
associated with the sensitivity of human H3N2 virus to MBL and
144 for 2009pdm H1N1 [28]. Notably, additional NGS at Site 133 in
HA emerged in some H7N9 strain (4 out of 269) and the effect of
MBL on it needed further tests. Similarly, only three NGS at 86, 146and 200 on NA head were found in H7N9 and additional sites
including 239, 329 and 402 in H3N2 and 239 and 402 in H9N2. Even
the distances of NGS in H7N9 NAwere less than 30 Å, we could not
detect any NAI effect of MBL on it. The ﬁndings might attribute to
the absence of effective NGS adjacent to NA functional region, such
as 239 and 402 in both H3N2 and H9N2 virus, or different glycan
type attached.
4. Discussion
Inﬂuenza A virus circulating in animal reservoirs is a continual
cause for public health concern. In addition to the ever-present
threat of seasonal inﬂuenza, we also face the threats from novel
viruses such as H5N1 and H7N9, 2009pdm H1N1 virus in recent
years. Since the viruses can escape from the protection of anti-HA
or anti-NA antibodies due to antigenic shift, the innate immunity
in naïve host is crucial for battling against newly-emerging viruses.
MBL, a pattern-recognition molecule in innate immunity, is
known as a b inhibitor for seasonal inﬂuenza A virus. The average
concentration of MBL in healthy human plasma (aged 18e87years)
is 1.72 ± 1.51 mg/mL [29], with about 30% of individuals presentMBL
levels below 0.5 mg/mL [30]. The antiviral activity of MBL against
seasonal inﬂuenza A virus is via its interactions with viral HA or NA
by blocking viral entry, fusion or releasing [15,31]. MBL could
neutralize the virus either in a complement dependent or inde-
pendent manner [13,15], However, the effects of MBL may vary
depending on speciﬁc strains. It also plays an important role in
modulating inﬂammation and has been reported to contribute to
deleterious inﬂammatory response to pdmH1N1 and a H9N2 avian
isolate (A/Quail/Hong Kong/G1/97) [32].
Here, we found differential binding of rhMBL to human inﬂu-
enza H3N2 and avian H7N9, H9N2 viruses. Speciﬁcally, rhMBL
exhibited signiﬁcant HI activity against H3N2 and H9N2 virus at a
relatively low concentration (0.026 ± 0.005, 0.083 ± 0.02, respec-
tively), while its HI activity on H7N9 virus was around
3.67 ± 0.33 mg/mL, reaching the upper limit in plasma of healthy
population. In contrast, for NAI on H7N9 virus, the rhMBL showed
little effect even at a high concentration as 10 mg/mL. As MBL is
supposed to display a steric interference with HA or NA when
binding to the speciﬁc hexose sugars across or adjacent to RBD in
HA or activity region in NA, the limited impact of MBL on H7N9
might result from its property of few NGS adjacent to functional
region on the HA and NA. Of note, a serial of pathotypings including
higher virus load, excess chemokine/cytokine response and
J. Guo et al. / Biochemical and Biophysical Research Communications 458 (2015) 77e81 81functional impairments of B and T cells have been observed in
H7N9 infection cases, particularly in fatal cases [33,34]. The aber-
rant inﬂammatory response in H7N9-infected animals could be
reversed partially by anti-C5a, indicating a hyperactivated com-
plement mediated [35]. Therefore, the strong MBL-H7N9 virus
interaction whereas limited effects on viral HA-receptor binding or
NA-mediated releasing, might amplify immune dysfunctions in vivo
and confer clinical severity of H7N9 infection via activating com-
plement pathway and further investigates are needed.
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